Literature DB >> 10881454

Prescriptions, power and politics: the turbulent history of methadone maintenance in Canada.

B Fischer1.   

Abstract

Illicit opiate addiction has emerged as a major problem in many Western countries in the second half of this century, and its social harm implications have become much exacerbated with the onset of the HIV epidemic in the 1980s. By now, most Western jurisdictions have resorted to methadone treatment as the most effective and best researched intervention against the negative consequences of opiate addiction including mortality, morbidity, crime, and loss of social functioning. Methadone treatment in Canada features a long, turbulent, and instructive history as an exemplary case study in public policy. While both Britain and the U.S. experimented with opiate prescription treatment in the first half of the century, Canadian proposals for such programs initially never made it beyond the discussion stage, largely due to the influential resistance from the law enforcement sector. However, in light of growing influence from an emerging addictions treatment sector, Canada became the first Western jurisdiction to experiment with methadone prescription for the treatment of opiate addiction forty years ago. Methadone treatment became quickly and widely established as an effective treatment modality through the 1960s. But in the early 1970s, resistance from the law and health sectors evolved, and triggered the government to establish a set of comprehensive and restrictive federal methadone treatment regulations, which have dominated its realities until today. Almost completely regulated out of existence by the end of the 1970s, methadone treatment's prevalence gradually increased again through the 1980s, and recent decentralization efforts to provincial levels earlier this decade have had dramatic effects on treatment availability. Significant events in the Canadian history of methadone treatment and its regulation reflect developments in the U.S., and substantial recent domestic treatment expansion developments--as well as renewed sparks of resistance--are reminiscent of methadone treatment's patterns of history as they developed in the late 1960s. This paper traces the turbulent history of methadone treatment, regulation and policy in Canada with particular attention to institutional, professional and political determinants at the complex intersection of health, law, and addiction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881454

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  22 in total

1.  Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.

Authors:  Ryan McNeil; Thomas Kerr; Solanna Anderson; Lisa Maher; Chereece Keewatin; M J Milloy; Evan Wood; Will Small
Journal:  Soc Sci Med       Date:  2015-04-07       Impact factor: 4.634

2.  Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study).

Authors:  Benedikt Fischer; Jürgen Rehm; Suzanne Brissette; Serge Brochu; Julie Bruneau; Nady El-Guebaly; Lina Noël; Mark Tyndall; Cameron Wild; Phil Mun; Dolly Baliunas
Journal:  J Urban Health       Date:  2005-05-04       Impact factor: 3.671

Review 3.  The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight.

Authors:  Joseph K Eibl; Kristen Morin; Esa Leinonen; David C Marsh
Journal:  Can J Psychiatry       Date:  2017-05-19       Impact factor: 4.356

Review 4.  Pregnancy and isotretinoin therapy.

Authors:  June Seek Choi; Gideon Koren; Irena Nulman
Journal:  CMAJ       Date:  2013-01-07       Impact factor: 8.262

5.  Is there a need for heroin substitution treatment in Vancouver's Downtown Eastside? Yes there is, and in many other places too.

Authors:  Martin T Schechter; Perry Kendall
Journal:  Can J Public Health       Date:  2011 Mar-Apr

6.  Effect of low-threshold methadone maintenance therapy for people who inject drugs on HIV incidence in Vancouver, BC, Canada: an observational cohort study.

Authors:  Keith Ahamad; Kanna Hayashi; Paul Nguyen; Sabina Dobrer; Thomas Kerr; Christian G Schütz; Julio S Montaner; Evan Wood
Journal:  Lancet HIV       Date:  2015-08-06       Impact factor: 12.767

7.  Patterns of methadone maintenance treatment provision in Ontario: Policy success or pendulum excess?

Authors:  Paul Kurdyak; Binu Jacob; Juveria Zaheer; Benedikt Fischer
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

8.  Prevalence of Heavy Alcohol Use Among People Receiving Methadone Following Change to Methadose.

Authors:  Jan Klimas; Evan Wood; Ekaterina Nosova; M-J Milloy; Thomas Kerr; Kanna Hayashi
Journal:  Subst Use Misuse       Date:  2017-06-12       Impact factor: 2.164

9.  Socio-spatial stigmatization and the contested space of addiction treatment: remapping strategies of opposition to the disorder of drugs.

Authors:  Christopher B R Smith
Journal:  Soc Sci Med       Date:  2009-11-26       Impact factor: 4.634

10.  Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.

Authors:  Gerald Cochran; Julie Bruneau; Nicholas Cox; Adam J Gordon
Journal:  Subst Abus       Date:  2020       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.